A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.

NCT ID: NCT00502840

Last Updated: 2017-08-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

193 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-23

Study Completion Date

2011-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single arm study will evaluate the efficacy and safety of repeated courses of MabThera in patients with active rheumatoid arthritis who have participated in ML19070, and have completed the week 24 visit. Eligible patients (DAS28 \>2.6 after week 24), will receive 2 infusions of 1g MabThera (Day 1 and day 15). For all patients in this extension study, up to 3 repeated courses of treatment are allowed. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

rituximab [MabThera/Rituxan]

Intervention Type DRUG

1g iv on days 1 and 15

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rituximab [MabThera/Rituxan]

1g iv on days 1 and 15

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit;
* eligible for re-treatment (DAS28 \>2.6 after week 24, swollen joint count \>=4, tender joint count \>=4).

Exclusion Criteria

* patients who have withdrawn from treatment in ML19070 pre-week 16;
* patients with a previous response in DAS28 \<0.6 to MabThera after week 16;
* concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rheumapraxis - Dres. Edmund Edelmann, Gerhard Straeßner und Hans Bloching

Bad Aibling, , Germany

Site Status

Rheuma-Klinikum Bad Bramstedt Klinik fuer Rheumatologie und Immunologie

Bad Bramstedt, , Germany

Site Status

Campus Charité Mitte Charité Centrum 12. Med.Klinik Abt.Rheumatologie u.Klin.Immunologie

Berlin, , Germany

Site Status

Praxis Dr. Silke Zinke

Berlin, , Germany

Site Status

Immanuel-Krankenhaus; Rheumklinik Berlin Buch

Berlin, , Germany

Site Status

Ev. Waldkrankenhaus Spandau; Klinik für Innere Medizin

Berlin, , Germany

Site Status

Ambulantes Rheumazentrum Dr.med. Helmut Sörensen

Berlin, , Germany

Site Status

Universitätsklinikum Bonn Med. Klinik u.Poliklinik III

Bonn, , Germany

Site Status

Klinik der Uni zu Köln; Klinik für Innere Medizin

Cologne, , Germany

Site Status

HELIOS Seehospital Sahlenburg Abt.Internist.Rheumatologie

Cuxhaven, , Germany

Site Status

Praxis PD Dr. med. Ekkehard Röther

Donaueschingen, , Germany

Site Status

Rheumatologisches MVZ Dresden GmbH, Dres. Holger Schwenke, Reiner Schwenke, Annekatrin Georgi

Dresden, , Germany

Site Status

Med. Versorgungszentrum Kästner + Kästner GbR Ambulantes Rheumazentrum

Erfurt, , Germany

Site Status

Universitätsklinikum Erlangen; Medizinische Klinik 3; Rheumatologie und Immunologie

Erlangen, , Germany

Site Status

Kliniken Essen; Süd Kath.Krankenhaus St.Josef; Abt. Rheumatologie und Immunologie

Essen, , Germany

Site Status

Klinik Johann Wolfgang von Goethe Uni; Medizinische Klinik II; Abt. Rheumatologie

Frankfurt am Main, , Germany

Site Status

Universitätsklinikum Freiburg; Medizinische UNI-Klinik; Abt. Innere Medizin - VI Rheumatologie

Freiburg im Breisgau, , Germany

Site Status

Herz-Jesu-Krankenhaus Abt.Geriatrie u. Rheumatologie

Fulda, , Germany

Site Status

Universitätsklinikum Gießen und Marburg GmbH Standort Gießen Medizinische Klinik III

Giessen, , Germany

Site Status

MEDIGREIF Fachkrankenhaus fuer Rheumatologie und Orthopädie; Vogelsang-Gommern

Gommern, , Germany

Site Status

Evangelisches Krankenhaus Hagen-Haspe Rheumaklinik

Hagen, , Germany

Site Status

Universitätsklinikum Halle Klinik u.Poliklinik f.Innere Medizin I

Halle, , Germany

Site Status

Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie

Hamburg, , Germany

Site Status

Medizinische Hochschule Zentrum Innere Medizin Abt.Klinische Immunologie und Rheumatologie

Hanover, , Germany

Site Status

Rheumapraxis PD Dr.med. Bernhard Heilig

Heidelberg, , Germany

Site Status

UNI-Klinikum Heidelberg Medizinische Klinik Innere Medizin V

Heidelberg, , Germany

Site Status

Rheumazentrum-Ruhrgebiet, St. Josefs-Krankenhaus; Rheumatologie

Herne, , Germany

Site Status

Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I

Homburg/Saar, , Germany

Site Status

Universitätsklinikum Jena; Klinik für Innere Medizin III

Jena, , Germany

Site Status

Praxis Dr.med. Ursula Mauß-Etzler

Karlsruhe, , Germany

Site Status

Klinikum der Stadt Ludwigshafen; Medizinische Klinik A

Ludwigshafen, , Germany

Site Status

Praxis Andreas Reck

Mittelherwigsdorf, , Germany

Site Status

LMU München, Bereich Pettenkoferstr., Medizinische Poliklinik

München, , Germany

Site Status

Praxis Prof. Dr.med. Herbert Kellner

München, , Germany

Site Status

Gemeinschaftspraxis Prof. Dr. med. Klaus Krueger, Guenter Kellerer und Paul Kellerer

München, , Germany

Site Status

Universitätsklinikum Münster Innere Medizin B

Münster, , Germany

Site Status

Praxis Dr.med. Sylvia Berger

Naunhof, , Germany

Site Status

Evang.Krankenhaus Medizinische Klinik

Oldenburg, , Germany

Site Status

Rheumapraxis an der Hase

Osnabrück, , Germany

Site Status

Praxis Dr.med. Anett Gräßler

Pirna, , Germany

Site Status

Evangelisches Fachkrankenhaus; Rheumaklinik

Ratingen, , Germany

Site Status

Klinikum der Uni Regensburg; Klinik f.Innere Medizin I Abt. Hämatologie und Internistische Onkologie

Regensburg, , Germany

Site Status

Praxis Dr.med. Matthias Richter

Rostock, , Germany

Site Status

St.-Josef-Stift Klinik für Rheumatologie

Sendenhorst, , Germany

Site Status

Rheumatologische Schwerpunktpraxis am Feuersee

Stuttgart, , Germany

Site Status

Johanniter-Krankenhaus im Fläming Treuenbrietzen GmbH; Fachklinik Pneumologie/ Thoraxchirurgie

Treuenbrietzen, , Germany

Site Status

Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin II

Tübingen, , Germany

Site Status

Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo.

Ulm, , Germany

Site Status

Praxis Dr.med. Wolf-Dieter Wörth

Wiesbaden, , Germany

Site Status

Medizinisches Zentrum Betriebsteil Marienhöhe Klinik f.Internistische Rheumatologie

Würselen, , Germany

Site Status

Universitätsklinikum Würzburg; Medizinische Klinik und Poliklinik II; Hämatologie / Onkologie

Würzburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Dimanche A, Bervini D, Miller DR, Schar A, Goldberg J, Raabe A, Dunn AK. Cortical perfusion measurements with laser speckle contrast imaging during adenosine induced cardiac arrest for aneurysm clipping: a case report. Acta Neurochir (Wien). 2024 Jan 23;166(1):27. doi: 10.1007/s00701-024-05925-2.

Reference Type DERIVED
PMID: 38261093 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ML19071

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.